![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](//imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif) | Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | 5/5/2041 (Ruxolitinib); 3/14/2034 (Tofacitinib); 12/3/2034 (Ritlecitinib); 11/30/2032 (Baricitinib); 2/19/2034 (Abrocitinib) | View detail » | 2016 |
 | CAS No. 1207853-23-3, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1227917-63-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1207947-49-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No.151266-23-8, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2017 |
![Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-](//imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijlioin/2778223-60-60.gif) | Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- | Pralsetinib | 4/3/2039 (Pralsetinib) | View detail » | 2022 |
 | CAS No.171290-52-1, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2023 |
 | CAS No.109431-87-0, Futibatinib Intermediate | Futibatinib | 11/05/2039 (Futibatinib) | View detail » | 2020 |
 | CAS No. 6228-73-5, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | |
 | CAS No. 1352925-63-3, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 372118-00-8, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2022 |
 | CAS No. 1609393-89-6, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 679406-03-2, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | |
 | CAS No. 1609394-10-6, Deucravacitinib intermediate | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2023 |
 | CAS No. 7436-22-8, Deuterium source | Deucravacitinib | 11/7/2033 (Deucravacitinib) | View detail » | 2018 |
 | Cas No. 2296729-00-3, Sotorasib | Sotorasib | 9/15/2040 (Sotorasib) | View detail » | |
 | CAS No. 1346623-11-7 | Avacopan | 5/29/2041 (Avacopan) | View detail » | 2023 |
 | CAS No. 1357259-88-1 | Avacopan | 5/29/2041 (Avacopan) | View detail » | 2019 |
 | CAS No. 838-57-3, ethyl 3-(4-nitrophenyl)-3-oxopropanoate | Avacopan | 5/29/2041 (Avacopan) | View detail » | 2020 |
 | CAS No. 1146629-83-5, (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Ruxolitinib | 5/5/2041 (Ruxolitinib) | View detail » | 2022 |
![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif)
![Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-](http://imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijlioin/2778223-60-60.gif)
